Clinical Trial Update: Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial examining hepatic arterial infusion of floxuridine and dexamethasone with bevacizumab in patients with unresectable primary liver cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• DEXAMETHASONE (Dexamethasone)
• Floxuridine (floxuridine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-10